[HTML][HTML] Thioredoxin Reductase and Organometallic Complexes: A Pivotal System to Tackle Multidrug Resistant Tumors?
M Salmain, M Gaschard, M Baroud, E Lepeltier… - Cancers, 2023 - mdpi.com
Simple Summary The identification of biological targets is an essential step in deciphering
the mechanism of action of anticancer drugs. In this review, we chose to study the …
the mechanism of action of anticancer drugs. In this review, we chose to study the …
[HTML][HTML] Thioredoxin Reductase and Organometallic Complexes: A Pivotal System to Tackle Multidrug Resistant Tumors?
M Salmain, M Gaschard, M Baroud, E Lepeltier… - Cancers, 2023 - ncbi.nlm.nih.gov
Cancers classified as multidrug-resistant (MDR) are a family of diseases with poor prognosis
despite access to increasingly sophisticated treatments. Several mechanisms explain these …
despite access to increasingly sophisticated treatments. Several mechanisms explain these …
Thioredoxin Reductase and Organometallic Complexes: A Pivotal System to Tackle Multidrug Resistant Tumors?
M Salmain, M Gaschard, M Baroud, E Lepeltier… - Cancers, 2023 - cnrs.hal.science
Cancers classified as multidrug-resistant (MDR) are a family of diseases with poor prognosis
despite access to increasingly sophisticated treatments. Several mechanisms explain these …
despite access to increasingly sophisticated treatments. Several mechanisms explain these …
Thioredoxin Reductase and Organometallic Complexes: A Pivotal System to Tackle Multidrug Resistant Tumors?
M Salmain, M Gaschard, M Baroud, E Lepeltier… - …, 2023 - search.proquest.com
Cancers classified as multidrug-resistant (MDR) are a family of diseases with poor prognosis
despite access to increasingly sophisticated treatments. Several mechanisms explain these …
despite access to increasingly sophisticated treatments. Several mechanisms explain these …
Thioredoxin Reductase and Organometallic Complexes: A Pivotal System to Tackle Multidrug Resistant Tumors?
M Salmain, M Gaschard, M Baroud, E Lepeltier… - …, 2023 - univ-angers.hal.science
Cancers classified as multidrug-resistant (MDR) are a family of diseases with poor prognosis
despite access to increasingly sophisticated treatments. Several mechanisms explain these …
despite access to increasingly sophisticated treatments. Several mechanisms explain these …
Thioredoxin Reductase and Organometallic Complexes: A Pivotal System to Tackle Multidrug Resistant Tumors?
M Salmain, M Gaschard, M Baroud, E Lepeltier… - Cancers, 2023 - hal.science
Cancers classified as multidrug-resistant (MDR) are a family of diseases with poor prognosis
despite access to increasingly sophisticated treatments. Several mechanisms explain these …
despite access to increasingly sophisticated treatments. Several mechanisms explain these …
Thioredoxin Reductase and Organometallic Complexes: A Pivotal System to Tackle Multidrug Resistant Tumors?
M Salmain, M Gaschard, M Baroud, E Lepeltier… - Cancers, 2023 - go.gale.com
The identification of biological targets is an essential step in deciphering the mechanism of
action of anticancer drugs. In this review, we chose to study the relationship between the …
action of anticancer drugs. In this review, we chose to study the relationship between the …
Thioredoxin Reductase and Organometallic Complexes: A Pivotal System to Tackle Multidrug Resistant Tumors?
M Salmain, M Gaschard, M Baroud, E Lepeltier… - …, 2023 - search.ebscohost.com
Abstract Simple Summary: The identification of biological targets is an essential step in
deciphering the mechanism of action of anticancer drugs. In this review, we chose to study …
deciphering the mechanism of action of anticancer drugs. In this review, we chose to study …
Thioredoxin Reductase and Organometallic Complexes: A Pivotal System to Tackle Multidrug Resistant Tumors?
M Salmain, M Gaschard, M Baroud, E Lepeltier… - Cancers, 2023 - europepmc.org
Cancers classified as multidrug-resistant (MDR) are a family of diseases with poor prognosis
despite access to increasingly sophisticated treatments. Several mechanisms explain these …
despite access to increasingly sophisticated treatments. Several mechanisms explain these …
Thioredoxin Reductase and Organometallic Complexes: A Pivotal System to Tackle Multidrug Resistant Tumors?
M Salmain, M Gaschard, M Baroud, E Lepeltier… - …, 2023 - pubmed.ncbi.nlm.nih.gov
Cancers classified as multidrug-resistant (MDR) are a family of diseases with poor prognosis
despite access to increasingly sophisticated treatments. Several mechanisms explain these …
despite access to increasingly sophisticated treatments. Several mechanisms explain these …